John F. Miller

2.1k total citations
56 papers, 1.3k citations indexed

About

John F. Miller is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, John F. Miller has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 15 papers in Molecular Biology and 13 papers in Infectious Diseases. Recurrent topics in John F. Miller's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). John F. Miller is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). John F. Miller collaborates with scholars based in United States, France and Ireland. John F. Miller's co-authors include Anthony D. Piscopio, Kevin M. Koch, Andrew Spaltenstein, Kristjan S. Gudmundsson, Elizabeth M. Turner, A. E. Austin, Herbert K. Proudfit, Michael M. Thomson, Pat Wheelan and Lanny S. Liebeskind and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

John F. Miller

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John F. Miller United States 23 521 430 162 128 115 56 1.3k
John E. Starrett United States 19 298 0.6× 901 2.1× 155 1.0× 44 0.3× 62 0.5× 26 1.6k
Robert E. Hughes United States 31 381 0.7× 1.6k 3.7× 31 0.2× 33 0.3× 89 0.8× 63 3.0k
Hubert Köster Germany 28 312 0.6× 2.1k 4.8× 54 0.3× 14 0.1× 99 0.9× 88 3.0k
Elena Ferrari Italy 29 105 0.2× 1.4k 3.4× 70 0.4× 44 0.3× 356 3.1× 74 2.5k
William H. Saunders United States 27 947 1.8× 305 0.7× 37 0.2× 3 0.0× 141 1.2× 177 2.7k
Vladislav A. Litosh United States 17 228 0.4× 319 0.7× 22 0.1× 14 0.1× 34 0.3× 32 1.0k
Guimin Wang China 24 135 0.3× 434 1.0× 13 0.1× 12 0.1× 138 1.2× 84 1.7k
Luke J. Leman United States 23 313 0.6× 1.2k 2.8× 16 0.1× 11 0.1× 86 0.7× 34 1.7k
Werner Jahn Germany 24 606 1.2× 925 2.2× 37 0.2× 3 0.0× 93 0.8× 80 2.4k
Takeshi Baba Japan 28 149 0.3× 1.2k 2.8× 39 0.2× 4 0.0× 165 1.4× 92 2.5k

Countries citing papers authored by John F. Miller

Since Specialization
Citations

This map shows the geographic impact of John F. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Miller more than expected).

Fields of papers citing papers by John F. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Miller. The network helps show where John F. Miller may publish in the future.

Co-authorship network of co-authors of John F. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Miller. A scholar is included among the top collaborators of John F. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Miller. John F. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kazmierski, Wieslaw M., Bing Xia, John F. Miller, et al.. (2020). DNA-Encoded Library Technology-Based Discovery, Lead Optimization, and Prodrug Strategy toward Structurally Unique Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors. Journal of Medicinal Chemistry. 63(7). 3552–3562. 50 indexed citations
2.
Chong, Pek Y., J. Brad Shotwell, John F. Miller, et al.. (2019). Design of N -Benzoxaborole Benzofuran GSK8175—Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor. Journal of Medicinal Chemistry. 62(7). 3254–3267. 45 indexed citations
3.
4.
5.
Miller, John F., Elizabeth M. Turner, Kristjan S. Gudmundsson, et al.. (2010). Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents. Bioorganic & Medicinal Chemistry Letters. 20(7). 2125–2128. 77 indexed citations
6.
Catalano, John G., Kristjan S. Gudmundsson, Sharon Boggs, et al.. (2010). Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 20(7). 2186–2190. 34 indexed citations
7.
Gudmundsson, Kristjan S., Paul R. Sebahar, John F. Miller, et al.. (2009). Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 19(17). 5048–5052. 44 indexed citations
8.
Miller, John F., Elizabeth M. Turner, Ronald G. Sherrill, et al.. (2009). Substituted tetrahydro-β-carbolines as potential agents for the treatment of human papillomavirus infection. Bioorganic & Medicinal Chemistry Letters. 20(1). 256–259. 30 indexed citations
9.
10.
Spaltenstein, Andrew, Wieslaw M. Kazmierski, John F. Miller, & Vicente Sámano. (2005). Discovery of Next Generation Inhibitors of HIV Protease. Current Topics in Medicinal Chemistry. 5(16). 1589–1607. 21 indexed citations
11.
Miller, John F., Eric S. Furfine, Richard Hazen, et al.. (2005). Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles. Bioorganic & Medicinal Chemistry Letters. 15(15). 3496–3500. 15 indexed citations
12.
Miller, John F., Eric S. Furfine, Mary H. Hanlon, et al.. (2004). Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains. Bioorganic & Medicinal Chemistry Letters. 14(4). 959–963. 16 indexed citations
13.
Miller, John F., Andreas Termin, Kevin M. Koch, & Anthony D. Piscopio. (1998). Stereoselective Synthesis of Functionalized Carbocycles and Heterocycles via an Ester Enolate Claisen/Ring-Closing Metathesis Manifold,. The Journal of Organic Chemistry. 63(10). 3158–3159. 39 indexed citations
14.
Smith, Gary K., Todd A. Blumenkopf, Michael Cory, et al.. (1997). Toward Antibody-directed Enzyme Prodrug Therapy with the T268G Mutant of Human Carboxypeptidase A1 and Novel in VivoStable Prodrugs of Methotrexate. Journal of Biological Chemistry. 272(25). 15804–15816. 42 indexed citations
15.
Miller, John F. & Andrew Spaltenstein. (1996). Formation and isolation of simple, stable, acyclic di- and tripeptide hemiacetals. Tetrahedron Letters. 37(15). 2521–2524. 9 indexed citations
16.
Miller, John F., et al.. (1995). 5-HT1B/1D agonist CGS-12066B attenuates clasp knife reflex in the cat. Journal of Neurophysiology. 74(1). 453–456. 7 indexed citations
17.
Miller, John F., et al.. (1995). Effect of reversible dorsal cold block on the persistence of inhibition generated by spinal reflexes. Experimental Brain Research. 107(2). 205–14. 3 indexed citations
18.
19.
Miller, John F., et al.. (1960). Properties of PbSe Prepared by Powder-Metallurgy Techniques. Journal of The Electrochemical Society. 107(11). 915–915. 3 indexed citations
20.
Miller, John F., et al.. (1959). Preparation of Anhydrous Rare Earth Chlorides for Physicochemical Studies1. Journal of the American Chemical Society. 81(17). 4449–4451. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John E. Starrett Breakdown of academic impact, for papers by Robert E. Hughes Breakdown of academic impact, for papers by Hubert Köster Breakdown of academic impact, for papers by Elena Ferrari Breakdown of academic impact, for papers by William H. Saunders Breakdown of academic impact, for papers by Vladislav A. Litosh Breakdown of academic impact, for papers by Guimin Wang Breakdown of academic impact, for papers by Luke J. Leman Breakdown of academic impact, for papers by Werner Jahn Breakdown of academic impact, for papers by Takeshi Baba
Rankless by CCL
2026